Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(13%)
Results Posted
100%(3 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_2
7
88%
Ph phase_3
1
13%

Phase Distribution

0

Early Stage

7

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
7(87.5%)
Phase 3Large-scale testing
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
Not yet recruiting2
Active, not recruiting1
Suspended1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 27 (87.5%)
Phase 31 (12.5%)

Trials by Status

completed338%
not_yet_recruiting225%
active_not_recruiting113%
suspended113%
terminated113%

Recent Activity

1 active trials
Showing 5 of 8
not_yet_recruitingphase_2

Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis

NCT07350174
terminatedphase_2

Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Tuberculosis

NCT06041919
active_not_recruitingphase_2

Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis

NCT06058299
completedphase_2

Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis

NCT04176250
completedphase_2

Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

NCT03338621
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07350174Phase 2

Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis

Not Yet Recruiting
NCT06041919Phase 2

Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Tuberculosis

Terminated
NCT06058299Phase 2

Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis

Active Not Recruiting
NCT04176250Phase 2

Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis

Completed
NCT03338621Phase 2

Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

Completed
NCT04694586Phase 2

Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide

Suspended
NCT05917340Phase 3

Intensified Short Course Regimen for TBM in Adults

Not Yet Recruiting
NCT02467608Phase 2

Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8